1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the blood and lymphatic system, such as a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the central nervous system, such as a quinolone group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the skin, such as a benzimidazole group, it is likely to cause adverse effects.
These rules are based on the properties and structures of the molecules and the known adverse effects of their functional groups. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a phosphate group (P(=O)(O)O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (Cl), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl, contains a phosphate group and a chlorine atom. It is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders. Therefore, this molecule is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The second molecule, CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C.C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O 1, contains a chlorine atom. It is also labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders. Therefore, this molecule is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The third molecule, C[C@@H](C(=O)N1CC2=CC(=C(C=C2C[C@H]1C(=O)O)OC)OC)N[C@@H](CCC3=CC=CC=C3)C(=O)O 1, contains a carbonyl group. It is also labeled as 1, which means it is related to

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a benzene ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F 0) contains a benzene ring and is labeled as 0, which means it is not related to adverse effects. The second molecule (CC#CCC(C)[C@@H](C=CC1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)C2)O)O 1) also contains a benzene ring and is labeled as 1, which means it is related to adverse effects. Therefore, the presence of a benzene ring in a molecule is a predictor of whether it is related to adverse effects.
2. Rule 2: The third molecule (CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N 1) contains a carbonyl group (-C=O) and is labeled as 1, which means it is related to adverse effects. The fourth molecule (CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 1) also contains a carbonyl group (-C=O) and is labeled as 1, which means it is related to adverse effects. Therefore, the presence

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for the presence of specific functional groups or atoms that are known to be associated with adverse effects.

================================

1. Rule 1: If a molecule contains a halogen atom (such as fluorine, chlorine, bromine, or iodine), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains an arsenic atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a phosphorus atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules are based on the observation that molecules containing halogen or arsenic atoms are often associated with adverse effects related to blood and lymphatic system disorders. Similarly, molecules containing phosphorus atoms are also known to have similar effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules are based on the observation that molecules with these functional groups are more likely to interact with biological molecules and cause adverse effects. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the potential adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group such as an amide group (-C=O-NH-) or a sulfonamide group (-SO2-NH-), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a chlorine atom (Cl) or a fluorine atom (F), it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group (-NO2) or a cyano group (-CN), it is likely to cause adverse effects related to central nervous system disorders.

================================

1. Rule 1: If the molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule has a high molecular weight, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (such as chlorine or fluorine), it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a chlorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Explanation:
- Rule 1: The presence of a nitro group (-NO2) in a molecule has been shown to be associated with adverse effects related to blood and lymphatic system disorders. For example, the molecule nitroglycerin (glyceryl trinitrate), which is commonly used as a vasodilator, contains a nitro group and is known to cause headaches, chest pain, and other side effects.
- Rule 2: The presence of a chlorine atom in a molecule has also been shown to be associated with adverse effects related to blood and lymphatic system disorders. For example, the molecule chlorpromazine, which is used as an antipsychotic medication, contains a chlorine atom and is known to cause extrapyramidal side effects such as tardive dyskinesia.
- Rule 3: The presence of a carbonyl group (-C=O) in a molecule has been shown to be associated with adverse effects related to blood and lymphatic system disorders. For example, the molecule aspirin (acetylsalicylic acid), which is commonly used as a pain reliever and antipyretic, contains a carbonyl group and is known to cause gastrointestinal bleeding and other side effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the risk of adverse effects on the blood and lymphatic system.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the blood and lymphatic system, such as a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the skin, such as a sulfonamide group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the eyes, such as a sulfonamide group, it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains any functional groups such as aldehydes, ketones, esters, amides, or carboxylic acids, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains any halogen atoms such as fluorine, chlorine, bromine, or iodine, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains any nitrogen-containing functional groups such as amines, amides, or nitriles, it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a halogen atom (such as fluorine, chlorine, bromine, or iodine), it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains any functional groups that are known to cause adverse effects on the blood and lymphatic system, such as alcohols, aldehydes, or carboxylic acids, it is likely to cause adverse effects.
2. Rule 2: If the molecule contains any functional groups that are known to cause adverse effects on the central nervous system, such as amines or amides, it is likely to cause adverse effects.
3. Rule 3: If the molecule contains any functional groups that are known to cause adverse effects on the reproductive system, such as estrogens or progestogens, it is likely to cause adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects unrelated to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects unrelated to blood and lymphatic system disorders.
These rules can be inferred by analyzing the structures and labels of the given molecules. For example, the first molecule contains a nitro group and is labeled as causing adverse effects related to blood and lymphatic system disorders. The second molecule contains a chlorine atom and is labeled as not causing adverse effects related to blood and lymphatic system disorders. The third molecule contains a carbonyl group and is labeled as not causing adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C 0) contains a nitro group (-NO2), which suggests that it may have adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The second molecule (CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C 1) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The third molecule (C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N 1) contains a carboxylic acid group (-COOH), which suggests that it may have adverse effects related to blood and lymphatic system disorders.
The fourth molecule (CCC1C(C(C(C(=O)C(CC(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O 0) also contains a carboxylic acid group (-COOH), which suggests that it may have adverse effects related to blood and lymphatic system disorders. However, this molecule also contains a carbonyl group (-C=O), which may contribute to its adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred by analyzing the labels and structures of the molecules in the data. For example, molecule C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O contains a benzene ring and a carbonyl group, which suggests that it is likely to cause adverse effects related to blood and lymphatic system disorders. Similarly, molecule CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C also contains a benzene ring and a carbonyl group, which suggests that it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
4. Rule 4: If the molecule contains a sulfur-containing functional group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
5. Rule 5: If the molecule contains a functional group that can form hydrogen bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
6. Rule 6: If the molecule contains a functional group that can form covalent bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
7. Rule 7: If the molecule contains a functional group that can form ionic bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
8. Rule 8: If the molecule contains a functional group that can form coordination bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
9. Rule 9: If the molecule contains a functional group that can form hydrogen bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
10. Rule 10: If the molecule contains a functional group that can form covalent bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
11. Rule 11: If the molecule contains a functional group that can form ionic bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
12. Rule 12: If the molecule contains a functional group that can form coordination bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
13. Rule 13: If the molecule contains a functional group that can form hydrogen bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
14. Rule 14: If the molecule contains a functional group that can form covalent bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
15. Rule 15: If the molecule contains a functional group that can form ionic bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
16. Rule 16: If the molecule contains a functional group that can form coordination bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
17. Rule 17: If the molecule contains a functional group that can form hydrogen bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
18. Rule 18: If the molecule contains a functional group that can form covalent bonds, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
19. Rule 19:

================================

1. Rule 1: If a molecule contains a functional group such as an amine or a hydroxyl group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N 1) contains a nitro group (-NO2), which is associated with adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The second molecule (CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-].C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N 1) contains a carbonyl group (-C=O), which is associated with adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The third molecule (C(C(C(C(C(CO)O)O)O)O)O 0) contains a halogen atom (-F), which is associated with adverse effects related to blood and lymphatic system disorders.
The fourth molecule (CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5 0) also contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The fifth molecule (C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-] 1) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The sixth molecule (C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H](C(=C[C@H](C2=O)[C@H]4[C@H](C4(C)C)C[C@H]3C)CO)O)O)C 0) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The seventh molecule (C1C2CNCC1C3=CC4=NC=CN=C4C=C23 1) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The eighth molecule (CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N 1) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The ninth molecule (CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O 1) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The tenth molecule (CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O 0) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The eleventh molecule (CC(C)C1=NC(=NC(=C1C=C[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C 1) contains a halogen atom (-F), but it is not associated with adverse effects related to blood and lymphatic system disorders.
The twelfth molecule (C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H](C(=C[C@H

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to central nervous system disorders.
These rules can be inferred by analyzing the labels assigned to the smiles strings in the provided data. For example, the first rule can be inferred by analyzing the label 1 assigned to the smiles string "C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O 1", which indicates that the molecule contains a nitro group and is related to blood and lymphatic system disorders. Similarly, the second and third rules can be inferred by analyzing the labels assigned to the smiles strings "Cl[Tl] 0" and "CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 1", respectively.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to central nervous system disorders.
These rules can be inferred by analyzing the structures of the molecules and their possible interactions with biological systems. The presence of certain functional groups or atoms in a molecule can indicate its potential to interact with specific biological targets, which can lead to adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogen atom (such as chlorine), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Explanation:
1. Rule 1 is based on the observation that molecules containing a carbonyl group (C=O) are often associated with adverse effects related to blood and lymphatic system disorders. This is because the carbonyl group can interact with proteins and enzymes in the body, leading to toxicity and adverse effects.
2. Rule 2 is based on the observation that molecules containing halogen atoms (such as chlorine) are often associated with adverse effects related to blood and lymphatic system disorders. This is because halogen atoms can interact with proteins and enzymes in the body, leading to toxicity and adverse effects.
3. Rule 3 is based on the observation that molecules containing a nitro group (-NO2) are often associated with adverse effects related to blood and lymphatic system disorders. This is because the nitro group can interact with proteins and enzymes in the body, leading to toxicity and adverse effects.

================================

1. Rule 1: The presence of a polar functional group such as an alcohol, amine, or carboxylic acid in a molecule can increase its potential to cause adverse effects.
2. Rule 2: The presence of a ring structure in a molecule can increase its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom such as fluorine, chlorine, bromine, or iodine in a molecule can increase its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these properties are more likely to cause adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further analysis and experimentation.

================================

1. Rule 1: The presence of a carbonyl group (-C=O) in a molecule is a common structural feature that is associated with adverse effects on the blood and lymphatic system.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also associated with adverse effects on the blood and lymphatic system.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is associated with adverse effects on the blood and lymphatic system.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F 1" contains a carbonyl group (-C=O) and is associated with adverse effects on the blood and lymphatic system.
2. Rule 2: The molecule with the smiles string "COC(=O)[C@@H]1[C@H]2CCC(N2CCCF)C[C@@H]1C3=CC=C(C=C3)I 0" contains a nitro group (-NO2) and is associated with adverse effects on the blood and lymphatic system.
3. Rule 3: The molecule with the smiles string "CCCCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]5CSSC[C@H](NC(=O)[

================================

1. Rule 1: If a molecule contains a functional group such as an amide group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a carboxylic acid group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the risk of adverse effects on the blood and lymphatic system.

================================

